Clinical trial
Trial of Adalimumab in Progressive Sarcoidosis
NCT00311246 · University of Chicago, Other · Terminated
Key facts
| NCT number | NCT00311246 |
|---|---|
| Title | Trial of Adalimumab in Progressive Sarcoidosis |
| Official title | A Prospective Open-Label Trial of Adalimumab in Progressive Sarcoidosis |
| Lead sponsor | University of Chicago, Other |
| Collaborators | Abbott Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoidosis |
| Intervention type | Drug |
| Interventions | Adalimumab |
| Enrollment | 11 |
| Start date | Apr 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Apr 5, 2006 |
| Last update posted | Aug 25, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: